Journey Medical Corporati...

NASDAQ: DERM · Real-Time Price · USD
7.26
0.00 (0.00%)
At close: Aug 15, 2025, 12:21 PM

Journey Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
15.01M 13.14M 13.62M 14.63M 14.86M 13.03M 15.26M 34.54M 17.17M 12.21M 15.97M 16.12M 18.29M 23.3M 17.52M 19.61M 15.29M 10.72M
Cost of Revenue
6M 4.79M 2.24M 5.29M 6.54M 6.82M 6.01M 6.43M 7.77M 6.45M 7.72M 7.22M 7.63M 8.2M 9.53M 11.17M 7.48M 3.91M
Gross Profit
9.01M 8.35M 11.38M 9.34M 8.31M 6.21M 9.24M 28.11M 9.4M 5.76M 8.25M 8.89M 10.66M 15.09M 7.99M 8.44M 7.8M 6.81M
Operating Income
-2.88M -3.32M 2.23M -2.89M -2.93M -10.09M -2.1M 17.25M -7.65M -9.56M -9.99M -9.49M -7.14M -910K -9.32M -12.65M -13.76M 585K
Interest Income
138K 149K 191K 188K 161K 217K 113K 8K 79K 122K 50K 3K 4K 3K n/a n/a n/a n/a
Pretax Income
-3.74M -4.07M 1.58M -2.39M -3.36M -10.44M -2.02M 16.88M -8.36M -10.14M -10.63M -10.07M -7.59M -1.27M -13.42M -14.02M -15.29M 364K
Net Income
-3.8M -4.07M 1.52M -2.39M -3.36M -10.44M -2.14M 16.79M -8.36M -10.14M -10.64M -10.08M -7.53M -1.38M -21.75M -10.65M -11.87M 268K
Selling & General & Admin
11.88M 10.57M 10.06M 11.4M 10.33M 8.42M 9.84M 8.64M 12.14M 13.29M 13.99M 15.57M 15.19M 14.71M 15.06M 10.76M 7.79M 6.23M
Research & Development
n/a 39K 218K 842K 913K 7.88M 1.5M 2.23M 1.77M 2.03M 4.26M 2.81M 2.61M 1.27M 1.99M 794K 13.77M n/a
Other Expenses
n/a 1.06M -1.13M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
11.88M 11.67M 9.15M 12.24M 11.24M 16.3M 11.35M 10.87M 13.91M 15.32M 18.24M 18.39M 17.8M 15.98M 17.05M 11.55M 21.57M 6.23M
Interest Expense
937K 891K 831K 758K 563K 548K 24K 268K 756K 650K 617K 559K 454K 389K 4.1M 1.37M 1.34M 221K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a -2.3M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
17.89M 16.46M 11.39M 17.52M 17.78M 23.12M 17.36M 17.29M 21.68M 21.77M 25.96M 25.61M 25.43M 24.18M 26.57M 22.72M 29.05M 10.13M
Income Tax Expense
60K n/a 61K n/a n/a n/a 126K 95K n/a n/a 13K 10K -64K 104K 8.34M -3.38M -3.42M 96K
Shares Outstanding (Basic)
23.29M 22.61M 22.15M 20.54M 19.99M 19.76M 19.32M 18.42M 18.01M 17.81M 17.73M 17.62M 17.46M 17.32M 13.23M 9.16M 9.13M 9.16M
Shares Outstanding (Diluted)
23.29M 22.61M 22.15M 20.54M 19.99M 19.76M 19.32M 21.03M 18.01M 17.81M 17.73M 17.62M 17.46M 17.32M 13.24M 9.16M 9.16M 9.16M
EPS (Basic)
-0.16 -0.18 0.07 -0.12 -0.17 -0.53 -0.11 0.91 -0.46 -0.56 -0.6 -0.57 -0.43 -0.08 -1.64 -1.16 -1.3 0.03
EPS (Diluted)
-0.16 -0.18 0.07 -0.12 -0.17 -0.53 -0.11 0.80 -0.46 -0.56 -0.6 -0.57 -0.43 -0.08 -1.64 -1.16 -1.3 0.03
EBITDA
-1.71M -2.1M 3.42M -795K -1.96M -9.06M -1.16M 17.99M -6.52M -8.39M -8.76M -8.47M -6.1M 154K -8.83M -11.97M -13M 1.17M
EBIT
-2.8M -3.18M 2.41M -1.63M -2.8M -9.89M -1.99M 17.15M -7.61M -9.49M -10.01M -9.51M -7.14M -885K -9.32M -12.65M -13.95M 585K
Depreciation & Amortization
1.09M 1.09M 1M 837K 839K 836K 838K 836K 1.09M 1.09M 1.25M 1.04M 1.04M 1.04M 491K 680K 762K 605K